Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000078003-26-000018·NextCure, Inc.
Schedule 13G ownership disclosure
NEXTCURE INC
Common Stock par value $0.001 per share · CUSIP: 65343E108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pfizer Inc. (IRS Identification No.: 13-5315170)
Shares: 157,646.00 · Class: 3.0%
- Pfizer Ventures (US) LLC (IRS Indentification No. 82-5524518 )
Shares: 131,109.00 · Class: 2.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-26-000018
- Form type
- SCHEDULE 13G/A
- Filer
- NextCure, Inc.
- CIK
- CIK 1661059
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership